androgen deprivation therapy

Videos

Real-World Treatment Patterns, Survival Outcomes in Metastatic Castration-Sensitive Prostate Cancer

02/25/2021

Stephen Freedland, MD, discusses study results exploring real-world evidence on survival outcomes among men with metastatic castration-resistant prostate cancer who initiated ADT or ADT combined with anti-androgens, docetaxel, or abiraterone.

Stephen Freedland, MD, discusses...

02/25/2021

Journal of Clinical Pathways

Videos

Apalutamide Plus ADT Improves Long-Term Survival in Metastatic Castration-Sensitive Prostate Cancer

02/14/2021

Journal of Clinical Pathways

News

Addition of ADT, Brachytherapy to External Beam Radiotherapy for Localized Prostate Cancer

06/03/2020

Androgen deprivation therapy (ADT) should be considered a critical component of treatment for men with intermediate- and high-risk prostate cancer regardless of radiotherapy delivery method, according to new...

...

06/03/2020

Journal of Clinical Pathways

Research in Review

ADT Not Associated With Increased Risk of Dementia for Patients With Prostate Cancer

02/01/2017

JCP Editors

Treating advanced prostate cancer with androgen deprivation therapy (ADT) does not increase risk of Alzheimer’s disease, according to research published in the Journal of Clinical Oncology. ADT is prescribed to men...

...

02/01/2017

Journal of Clinical Pathways

Research in Review

Identifying Risk of All-Cause Mortality In Men Being Treated for Prostate Cancer

01/17/2017

JCP Editors

Men being treated for prostate cancer who are at higher risk of dying as a result of treatment failure can be identified prior to PSA recurrence using a surrogate endpoint, according to a study published in JAMA...

Men...

01/17/2017

Journal of Clinical Pathways